Abstract
It is estimated that at least 30% of patients taking clozapine do not respond adequately, maintaining high severity of symptoms, especially psychotic symptoms, and such patients are termed resistant to clozapine (CRS). Several clozapine augmentation strategies have been tested for such condition, particularly addition with antipsychotics, but none showed significant superiority over place…